Acquisition by William McCombe of 101132 shares of Cytek Biosciences subject to Rule 16b-3
CTKB Stock | USD 5.30 0.12 2.21% |
About 62% of Cytek Biosciences' investor base is looking to short. The analysis of overall sentiment of trading Cytek Biosciences stock suggests that many investors are alarmed at this time. The current market sentiment, together with Cytek Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Cytek Biosciences stock news signals to limit their universe of possible portfolio assets.
Cytek |
Filed transaction by Cytek Biosciences Officer: Chief Financial Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at finance.yahoo.com
![]() |
Cytek Biosciences Fundamental Analysis
We analyze Cytek Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cytek Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cytek Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
Cytek Biosciences is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Cytek Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cytek Biosciences stock to make a market-neutral strategy. Peer analysis of Cytek Biosciences could also be used in its relative valuation, which is a method of valuing Cytek Biosciences by comparing valuation metrics with similar companies.
Peers
Cytek Biosciences Related Equities
TMCI | Treace Medical | 6.43 | ||||
SGHT | Sight Sciences | 3.78 | ||||
AXGN | Axogen | 3.02 | ||||
APYX | Apyx Medical | 2.94 | ||||
OFIX | Orthofix Medical | 2.16 | ||||
NPCE | Neuropace | 2.09 | ||||
RXST | Rxsight | 1.71 | ||||
LIVN | LivaNova PLC | 1.66 | ||||
LUNG | Pulmonx Corp | 1.49 | ||||
ELMD | Electromed | 0.83 | ||||
SRDX | SurModics | 0.02 | ||||
KIDS | Orthopediatrics Corp | 0.32 | ||||
INGN | Inogen | 1.76 | ||||
SSKN | STRATA Skin | 2.24 | ||||
TLIS | Talis Biomedical | 3.41 |
Complementary Tools for Cytek Stock analysis
When running Cytek Biosciences' price analysis, check to measure Cytek Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytek Biosciences is operating at the current time. Most of Cytek Biosciences' value examination focuses on studying past and present price action to predict the probability of Cytek Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytek Biosciences' price. Additionally, you may evaluate how the addition of Cytek Biosciences to your portfolios can decrease your overall portfolio volatility.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |